Ray Peck

About Ray Peck

Founder and CEO of VxP Pharma, Inc. VxP Pharma Inc. provides drug development services to most of the world\'s largest pharma companies, government entities, including biodefense, as well as countless small and virtual biotechs on almost every continent. VxP offers development as well as upstream and downstream biologics processing and purification for mammalian, microbial, and live virus vaccines. We work with most dosage forms, including sterile, lyophilized products, and oral. We also offer stand-alone sterile fill and finish services for vials, pre-filled syringes and as well as lyophilized products. Although the majority of our operations are located in the United States, some facilities are located in Europe and Asia. Most have been successfully audited by the US-FDA, as well as numerous international regulatory agencies, and all have a long track record of successful collaborations with global pharma and biotech clients, virtual companies, and everything in between. Our double digit growth, year after year, and the fact that a large part of our business comes from returning customers, shows that we are doing something right.

Experience

1. CEO

   Vxp Pharma And Vxp Biologics, Inc

   Jun 2010 — Present

   Ray is the founder and CEO of VxP Pharma Services Inc, as well as VxP Biologics, Inc. With over 25 years’ experience in front line business development, as well as sales management, Ray has worked in dozens of countries, and on almost every continent. He is multi-lingual, and has worked with Global “Big Pharma” clients, as well as with the entrepreneurs at small virtual companies. He has held positions of increasing responsibility including Director of North American and European – Pharma/Biotech Business Development, Director of Global of Strategic Accounts at Azopharma, Executive Director at CoreRx Pharma Services, and most recently as Founder and CEO of VxP Pharma Services, Inc and more recently, VxP Biologics, Inc. Ray’s focus has been in drug development services from discovery, to clinical trial materials, and to commercial manufacturing. This includes both small molecule and biologics, as well as cell line engineering, mammalian, microbial and vaccine development. Ray founded CRO Solutions in 2010, and the VxP Pharma brand was launched in 2013, and VxP Biologics in 2015. VxP has since grown to include labs and research facilities on several continents, and in almost every area of Pharmaceutical and Biotech development and manufacturing. Ray holds a BS from Michigan State. E-mail Ray at r•••••••@vxppharma.com

Education

• Michigan State University

  BS, Marketing/Chemistry

Skills

• Clinical Trials
• Drug Delivery
• High-Performance Liquid Chromatography (Hplc)
• Regulatory Affairs
• Lifesciences
• Life Sciences
• Chemistry
• Validation
• Product Development
• Technology Transfer
• Formulation
• Clinical Development
• Glp
• Hplc
• Business Development
• Good Laboratory Practice (Glp)
• Biotechnology
• CRO
• Commercialization
• Selling
• Start-Ups
• Sales
• Clinical Research
• Clinical Pharmacology
• Pharmaceutical Industry
• Fda
• CRO Management
• Laboratory
• Drug Development
• Biopharmaceuticals
• Pharmaceutics
• Drug Discovery
• U.s. Food and Drug Administration (Fda)
• Biotechnology Industry
• Oncology
• Vaccines